556 related articles for article (PubMed ID: 12138094)
1. Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved.
Pandini G; Frasca F; Mineo R; Sciacca L; Vigneri R; Belfiore A
J Biol Chem; 2002 Oct; 277(42):39684-95. PubMed ID: 12138094
[TBL] [Abstract][Full Text] [Related]
2. Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
Sacco A; Morcavallo A; Pandini G; Vigneri R; Belfiore A
Endocrinology; 2009 Aug; 150(8):3594-602. PubMed ID: 19443570
[TBL] [Abstract][Full Text] [Related]
3. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells.
Frasca F; Pandini G; Scalia P; Sciacca L; Mineo R; Costantino A; Goldfine ID; Belfiore A; Vigneri R
Mol Cell Biol; 1999 May; 19(5):3278-88. PubMed ID: 10207053
[TBL] [Abstract][Full Text] [Related]
4. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the Akt/Glycogen synthase kinase-3 axis by insulin-like growth factor-II via activation of the human insulin receptor isoform-A.
Scalia P; Heart E; Comai L; Vigneri R; Sung CK
J Cell Biochem; 2001; 82(4):610-8. PubMed ID: 11500939
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development.
Denley A; Wang CC; McNeil KA; Walenkamp MJ; van Duyvenvoorde H; Wit JM; Wallace JC; Norton RS; Karperien M; Forbes BE
Mol Endocrinol; 2005 Mar; 19(3):711-21. PubMed ID: 15576456
[TBL] [Abstract][Full Text] [Related]
7. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
9. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
10. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death.
Kiely PA; Sant A; O'Connor R
J Biol Chem; 2002 Jun; 277(25):22581-9. PubMed ID: 11964397
[TBL] [Abstract][Full Text] [Related]
11. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways.
Miele C; Rochford JJ; Filippa N; Giorgetti-Peraldi S; Van Obberghen E
J Biol Chem; 2000 Jul; 275(28):21695-702. PubMed ID: 10777488
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
Qiao M; Shapiro P; Kumar R; Passaniti A
J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
[TBL] [Abstract][Full Text] [Related]
13. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor I receptor activity in human medulloblastomas.
Del Valle L; Enam S; Lassak A; Wang JY; Croul S; Khalili K; Reiss K
Clin Cancer Res; 2002 Jun; 8(6):1822-30. PubMed ID: 12060623
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I-dependent signal transduction pathways leading to the induction of cell growth and differentiation of human neuroblastoma cell line SH-SY5Y: the roles of MAP kinase pathway and PI 3-kinase pathway.
Kurihara S; Hakuno F; Takahashi S
Endocr J; 2000 Dec; 47(6):739-51. PubMed ID: 11228049
[TBL] [Abstract][Full Text] [Related]
16. Increased insulin sensitivity in IGF-I receptor--deficient brown adipocytes.
Mur C; Valverde AM; Kahn CR; Benito M
Diabetes; 2002 Mar; 51(3):743-54. PubMed ID: 11872675
[TBL] [Abstract][Full Text] [Related]
17. IRS-1 tyrosine phosphorylation reflects insulin-induced metabolic and mitogenic responses in 3T3-L1 pre-adipocytes.
Telting D; van der Zon GC; Dorrestijn J; Maassen JA
Arch Physiol Biochem; 2001 Feb; 109(1):52-62. PubMed ID: 11471071
[TBL] [Abstract][Full Text] [Related]
18. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling.
Pandini G; Vigneri R; Costantino A; Frasca F; Ippolito A; Fujita-Yamaguchi Y; Siddle K; Goldfine ID; Belfiore A
Clin Cancer Res; 1999 Jul; 5(7):1935-44. PubMed ID: 10430101
[TBL] [Abstract][Full Text] [Related]
19. Receptor synergy of interleukin-6 (IL-6) and insulin-like growth factor-I in myeloma cells that highly express IL-6 receptor alpha [corrected].
Abroun S; Ishikawa H; Tsuyama N; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Kawano MM
Blood; 2004 Mar; 103(6):2291-8. PubMed ID: 14592826
[TBL] [Abstract][Full Text] [Related]
20. Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II.
Alvino CL; Ong SC; McNeil KA; Delaine C; Booker GW; Wallace JC; Forbes BE
PLoS One; 2011; 6(11):e27488. PubMed ID: 22140443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
